Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial
-
Published:2024-01
Issue:
Volume:42
Page:100953
-
ISSN:2666-6065
-
Container-title:The Lancet Regional Health - Western Pacific
-
language:en
-
Short-container-title:The Lancet Regional Health - Western Pacific
Author:
Batmunkh Tsetsegsaikhan, Moore Kerryn A.ORCID, Thomson Helen, Altangerel Bolor, Amraa Otgonjargal, Avaa Naranbaatar, Batbayar Lkhagvagaram, Batsukh Khishigjargal, Bright Kathryn, Burentogtokh Tsogjargal, Ha Do Lien Anh, Dorj Gantuya, Hart John D.ORCID, Javkhlantugs Khulan, Jigjidsuren Sarantsetseg, Justice Frances, Li Shuo, Licciardi Paul V.ORCID, Mashbaatar Khaliunaa, Mazarakis Nadia, Neal Eleanor F.G., Nguyen Cattram Duong, Ochirbat Batbayar, Tsolmon Bilegtsaikhan, Tuya Alimaa, Surenjav Unursaikhan, von Mollendorf Claire, Mulholland KimORCID
Funder
State Government of Victoria National Health and Medical Research Council
Subject
Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine
Reference29 articles.
1. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID study;Menni;Lancet Infect Dis,2022 2. WHO SAGE roadmap for prioritizing uses of Covid-19 vaccines,2022 3. Good practice statement on the use of second booster doses for COVID-19 vaccines,2022 4. Comparative effectiveness of 3 or 4 doses of mRNA and inactivated whole-virus vaccines against COVID-19 infection, hospitalization and severe outcomes among elderly in Singapore;Tan;Lancet Reg Health West Pacific,2022 5. Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV- vaccinated individuals compared with homologous BNT162b2 vaccination: results of a pilot prospective cohort study from Lebanon;Moghnieh;Vaccine,2021
|
|